2005
DOI: 10.1007/s11102-005-5227-6
|View full text |Cite
|
Sign up to set email alerts
|

Stimulation of the Hypothalamic-Pituitary-Adrenal Axis with the Opioid Antagonist Nalmefene

Abstract: Of the nalmefene doses we studied, 6 mg achieved the best combination of stimulation of ACTH and cortisol and fewest side effects. If further studies show a concordance between nalmefene and IHT, nalmefene testing could be used to assess the HPA axis in patients at risk for dysfunction of this axis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0
1

Year Published

2007
2007
2022
2022

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 13 publications
(8 citation statements)
references
References 46 publications
0
7
0
1
Order By: Relevance
“…Nalmefene injection produced a greater increase in ACTH and cortisol than naloxone, possibly indicating kappa-opioid receptor involvement in the regulation of the HPA axis (Schluger et al, 1998). A dose-dependent relationship and diurnal variation of ACTH and cortisol release involving an alpha-2 adrenergic mechanism (Geer et al, 2005) were also observed after naloxone administration (al-Damluji et al, 1990; Coiro et al, 1985; Delitala et al, 1994; Ehrenreich et al, 1987; Hernandez-Avila et al, 2003; Martin del Campo et al, 1994), but ACTH levels were not significantly elevated after naloxone infusion in 7 male high-dose methadone-maintained addicts. However, there was a significant and robust post-naloxone increase in ACTH levels in healthy controls (Gold et al, 1981).…”
Section: Discussionmentioning
confidence: 96%
“…Nalmefene injection produced a greater increase in ACTH and cortisol than naloxone, possibly indicating kappa-opioid receptor involvement in the regulation of the HPA axis (Schluger et al, 1998). A dose-dependent relationship and diurnal variation of ACTH and cortisol release involving an alpha-2 adrenergic mechanism (Geer et al, 2005) were also observed after naloxone administration (al-Damluji et al, 1990; Coiro et al, 1985; Delitala et al, 1994; Ehrenreich et al, 1987; Hernandez-Avila et al, 2003; Martin del Campo et al, 1994), but ACTH levels were not significantly elevated after naloxone infusion in 7 male high-dose methadone-maintained addicts. However, there was a significant and robust post-naloxone increase in ACTH levels in healthy controls (Gold et al, 1981).…”
Section: Discussionmentioning
confidence: 96%
“…The authors have suggested that perhaps subpopulations of patients under physiological or psychological stress may react to naltrexone with dysphoric symptoms. This has not been directly investigated, but there is evidence that the opioid system within areas of the limbic circuit could modulate the stress response in animals (i.e., opioids have been shown to reduce stress related neuroendocrine and autonomic responses) [84] and activate the hypothalamic–pituitary–adrenal (HPA) axis in humans [85,86].…”
Section: The Opioid System: μ‐Opioid Receptor Antagonistsmentioning
confidence: 99%
“…This is also supported by the fact that naloxone treatment did not stimulate cortisol secretion after hypophyseal stalk transection in gilts ( Estienne et al, 1988 ). Nevertheless, naloxone has been shown to induce ACTH release in healthy human subjects ( Geer et al, 2005 ) and the effect seems to be gender specifi c Chong et al, 2006 ). In conclusion, it seems that the central nervous beta adrenergic and opioidergic systems regulate the cortisol response to stres-sors differently.…”
Section: Discussionmentioning
confidence: 89%